PROVIDENCE – The R.I. Executive Office of Health & Human Services received $1.5 million from the settlement of allegations Mylan Inc. and Mylan Specialty LP knowingly underpaid rebates owed to the Medicaid program for the drugs EpiPen and EpiPen Jr. dispensed to Medicaid beneficiaries. The settlement, announced Nov. 17, resolves allegations that from July 29,
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber